Boronia pinnata Sm. (Rutaceae) is a plant that is widespread in New South Wales (Australia). Although there are no reports about the use of this species in the local ethnomedical traditions, recent investigations led to the characterization of several secondary metabolites, most belonging to the class of prenyloxyphenylpropanoids. Some of the compounds extracted from B. pinnata showed valuable biological properties, such as anti-inflammatory activity and in vitro inhibition of growth of Helicobacter pylori. The aim of this review is to cover what has been reported so far in the literature on the title plant from a phytochemical and pharmacological point of view.
KuzuyamaT, NoelJP, RichardSB, (2005) Structural basis for the promiscuous biosynthetic prenylation of aromatic natural products. Nature, 435, 983–987.
2.
Haagen-SmitJ. (1953) The biogenesis of terpenes. Annual Review of Plant Physiology, 4, 305–324.
3.
LichtenthalerHK. (1999) The 1-deoxy-D-xylulose-5-phosphate pathway of isoprenoid biosynthesis in plant. Annual Review of Plant Physiology. Molecular Biology, 50, 47–65.
4.
EpifanoF, GenoveseS, MenghiniL, CuriniM. (2007) Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry, 68, 939–953.
5.
Nazrul IslamSK, GreyAI, WatermanPG, AhasanM. (2002) Screening of eight alkaloids and ten flavonoids isolated from four species of the genus Boronia (Rutaceae) for antimicrobial activities against seventeen clinical microbial strains. Phytotherapy Research, 16, 672–674.
6.
AhsanM, GrayAI, LeachG, WatermanPG. (1993) Quinolone and acridone alkaloids from Boronia lanceolata. Phytochemistry, 33, 1507–1510.
7.
AhsanM, GrayAI, WatermanPG. (1994) 4-Quinolinone, 2-quinolinone, 9-acridanone and furoquinoline alkaloids from the aerial parts of Boronia bowmanii. Journal of Natural Products, 57, 670–672.
8.
AhsanM, ArmstrongJA, GibbonsS, GrayAI, WatermanPG. (1994) Novel O-prenylated flavonoids from two varieties of Boronia caerulescens. Phytochemistry, 37, 259–266.
9.
AhsanM, GrayAI, WatermanPG. (1994) Farnesyl acetophenone and flavanone compounds from the aerial parts of Boronia ramose. Journal of Natural Products, 57, 673–676.
10.
GhisalbertiEL. (1997) Phytochemistry of the Australian Rutaceae. Phytochemistry, 47, 163–176.
11.
BodkinF. (1993) The Essential Reference Guide to Native and Exotic Plants in Australia. In Encyclopaedia Botanica, Cornstalk Publishing, Sydney, Australia, 155–160.
12.
SmithHG. (1919) Essential oil of Boronia pinnata Sm. and the presence of elemicin. Proceeding Royal Society of Victoria, 32, 14–19.
13.
WelchMB, PenfoldAR. (1922) Two pinnate leaf Boronias and their essential oils. Journal and Proceedings of the Royal Society of New South Wales, 56, 196–209.
14.
MorrisonFR. (1921) The occurrence of rutin in the leaves of the Boronia (Rutaceae). Journal and Proceedings of the Royal Society of New South Wales, 55, 210–214.
15.
ItoC, ItoigawaM, FurukawaH, IchiishiE, MukainakaT, OkudaM, OgataM, TokudaH, NishinoH. (1999) Anti-tumor-promoting effects of phenylpropanoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Letters, 142, 49–54.
16.
ItoC, ItoigawaM, OtsukaT, TakudaH, NishinoH, FurukawaH. (2000) Constituents of Boronia pinnata. Journal of Natural Products, 63, 1344–1348.
17.
WangQ, HeK, HouZ. (2003) First synthesis of three naturally occurring O-prenylated phenylpropanoids. Youji Huaxue, 23, 182–186.
18.
CuriniM, EpifanoF, GenoveseS, MenghiniL, RicciD, FraternaleD, GiamperiL, BucchiniA.BellacchioE. (2006) Lipoxygenase inhibitory activity of boropinic acid, active principle from Boronia pinnata. Natural Product Communications, 1, 1141–1145.
19.
EpifanoF, MenghiniL, PagiottiR, AngeliniP, GenoveseS, CuriniM. (2006) In vitro inhibitory activity of boropinic acid against Helicobacter pylori. Bioorganic and Medicinal Chemistry Letters, 16, 5523–5525.
